tungstate has been researched along with tyrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, LA; Bornemann, S; Boxer, DH; Palmer, T; Pau, RN; Price, NC | 1 |
| Barberà, A; Domínguez, J; Fernàndez-Alvarez, J; Gomis, R; Guinovart, JJ; Muñoz, MC | 1 |
| Colville, K; Labandera, AM; Moorhead, GB; Ng, KKS; Uhrig, RG | 1 |
3 other study(ies) available for tungstate and tyrosine
| Article | Year |
|---|---|
Characterisation of the molybdenum-responsive ModE regulatory protein and its binding to the promoter region of the modABCD (molybdenum transport) operon of Escherichia coli.
Topics: Bacterial Proteins; Base Sequence; Binding Sites; Biological Transport; Circular Dichroism; DNA Footprinting; DNA Primers; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Molybdenum; Operon; Promoter Regions, Genetic; Protein Binding; Protein Structure, Secondary; Repressor Proteins; Spectrometry, Fluorescence; Transcription Factors; Transcription, Genetic; Tryptophan; Tungsten Compounds; Tyrosine | 1997 |
Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus; Glucose-6-Phosphate; Glycogen; Hyperglycemia; Hypoglycemic Agents; Islets of Langerhans; Liver; Male; Obesity; Phosphorylation; Rats; Rats, Zucker; Tungsten Compounds; Tyrosine | 2001 |
Structural basis for the preference of the
Topics: Amino Acid Sequence; Arabidopsis; Arabidopsis Proteins; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Models, Molecular; Mutation; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Conformation; Substrate Specificity; Tungsten Compounds; Tyrosine | 2018 |